San Francisco, 06 December 2018, The global cell surface marker detection market is expected to reach USD 6.49
billion by 2022, according to a new report by Grand View Research, Inc. This
growth in demand can be attributed to rise in incidence of oncology diseases
and other cell-associated disorders.
Rapid
introduction of advancements and automations in clinical laboratories is a key
factor affecting this industry. Incorporation of novel algorithms pertaining to
diagnosis and prognosis of chronic disorders is expected to fuel demand of this
market in the coming years.
Requirement
of solutions for data handling and interpretation of clinical conditions based
on obtained results are anticipated to enhance potential for R&D in this
sector, consequently driving market growth over the forecast period.
Access Full
Research Report On Cell Surface Marker Detection Market Analysis:
www.grandviewresearch.com/industry-analysis/cell-surface-marker-detection-market
www.grandviewresearch.com/industry-analysis/cell-surface-marker-detection-market
Further key findings from the report
suggest:
·
Flow cytometry devices
accounted for over 70% of the revenue generated in the industry for 2014. This
large share can be attributed to the growing advancement in these instruments
such as enhancement in efficiency and resolution of fluorescence-based cytometric
detectors. Furthermore, presence of large product portfolio of different
industry players operating in cytometry is responsible for large market share
of this technique.
·
Disease diagnosis and
identification accounted for over 50% of the revenue generated in the market
for 2014. High incidence rate of cell-associated disorders and oncology
diseases that need to be treated in order to curb the mortality rate are the
major drivers for growth of this segment.
·
Determination of novel drug
targets and development of biopharmaceuticals for prognosis of chronic diseases
is anticipated to propel growth of research and drug discovery sub-segment in
the coming years. With expected development of this segment, the sector will
witness lucrative growth over the forecast period.
·
North America accounted for the
largest share of this sector for 2014, as there are is significantly high
number of research and development projects ongoing in the region related to
cytological investigation for proteomics, genomics, and drug and vaccine
development. Growing need for biopharmaceuticals is also anticipated to fuel
regional growth.
·
North America dominated the
industry in 2014, with revenue estimated at USD 999.0 million. Presence of
sophisticated healthcare infrastructure and favorable government initiatives
with respect to analytical techniques and their applications for disease
diagnosis and drug development are some key factors likely to drive growth.
·
Asia Pacific is expected to
witness lucrative growth from 2015 to 2022 due to the presence of high-unmet
medical needs coupled with rapidly rising healthcare R&D investment and
growing medical expenditures in emerging economies of India and China
·
Key participants of the cell
surface marker detection industry include Siemens Healthcare, Nihon Kohden
Corporation, Sartorius, Janssen Diagnostics Inc., Grifols SA, Thermo Fisher
Scientific, BioRad Laboratories Inc., and F. Hoffman La Roche Ltd.
·
These participants are involved
in R&D for production of cell-specific antibodies and collaborations with
smaller entities operating in the market as well as with academic research
laboratories in order to maintain their market position and enter the untapped
market regions
Browse More Reports Of This
Category By Grand View Research At: www.grandviewresearch.com/industry/biotechnology
Grand View Research has
segmented cell surface marker detection market on the basis of product,
application, and region:
Cell
Surface Marker Detection Product Outlook (Market Revenue in USD Million, 2012 -
2022 )
·
Flow Cytometry
·
Hematology Analyzers
·
Reagents & Kits
Cell
Surface Marker Detection Application Outlook (Market Revenue in USD Million,
2012 - 2022 )
·
Disease Diagnosis &
Identification
·
Research & Drug Discovery
·
Others
Cell
Surface Marker Detection Regional Outlook (Market Revenue in USD Million, 2012
- 2022 )
·
North America
·
Europe
·
Asia Pacific
·
RoW
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-cell-surface-marker-detection-market
www.grandviewresearch.com/press-release/global-cell-surface-marker-detection-market
About Grand View Research
Grand View
Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/